CTRI/2024/05/068104
Not yet recruiting
Phase 3
A clinico biochemical study to evaluate the efficacy of collagen peptide supplements with an intervention of nonsurgical periodontal therapy and on salivary nitric oxide level in chronic periodontitis. - Nil
Yogita Kshirsagar0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Yogita Kshirsagar
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Minimum 20 natural teeth
- •Diagnosis: Chronic mild to moderate periodontitis
- •Probing depth: 3\-7mm
- •Clinical Attachment Loss: 2\-4mm
- •Bleeding on probing
- •Systemically healthy patients
- •Patient agreed to give the consent only are included
Exclusion Criteria
- •Tobacco\-smokers, electronic cigarette users, smokeless tobacco product users, alcohol users.
- •Individuals that had used antibiotics and/or steroids within the past 3\-month.
- •Individuals with any systemic diseases.
- •Lactating and/or pregnant females.
- •Completely edentulous individuals
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
The evaluation of safety and biological effects of cancer-killing virus vaccine given to patients with advanced brain tumoursMalignant neoplasm of brain, high-grade brain tumourCancerMalignant neoplasm of brainISRCTN51762486niversity of Leeds12
Active, not recruiting
Phase 1
A clinical study to evaluate the effect of rimantadine in patients with hepatitis C virus (HCV) infection alongside standard treatment with pegylated interferon and ribavirin.EUCTR2011-002781-21-GBeeds Teaching Hospitals22
Completed
Not Applicable
Study of relation between gum infection and pregnancy complicationsHealth Condition 1: null- women in their first trimester of pregnancy having severe periodontal diseaseCTRI/2015/02/005581Gujarat University160
Completed
Not Applicable
Evaluating the biological effects of pre-operative intravenous administration of JX-594 (thymidine kinase-deactivated Vaccinia virus plus GM-CSF) prior to planned surgical resection of locally advanced/poor prognosis or metastatic cancers.ISRCTN13913966niversity of Leeds40
Completed
Not Applicable
Quantification of Clinically Relevant Drug Induced Changes in HbO2 AffinityOxygen DeficiencyNCT04612270Medical University Innsbruck22